Regensburg, February 9th, 2007 - GENEART AG, the world’s leading specialist in the production and optimization of synthetic genes, has once again significantly improved sales and earnings in 2006. Preliminary data show an increase in sales by more than 70% from EUR 4.5M in 2005 to EUR 7.8M in 2006. In this time, total revenues have increased by 65% to EUR 7.9M. Having passed the threshold to becoming a profitable company in 2005 with earnings of EUR 0.1M (EBIT), GENEART has now been able to fulfill positive expectations for more than proportionate earnings increases and achieved a result of EUR 1.0M (EBIT).
